Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD - 9-MTH group results

Feb 4 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              214.30              211.34           283.00    
                   (+1.4 pct)          (+5.7 pct)       (-1.9 pct)  
  Operating           20.86               17.09            21.00    
                   (+22.1 pct)         (-39.2 pct)      (-0.7 pct)  
  Recurring           24.74               20.27            25.50    
                   (+22.0 pct)         (-43.9 pct)      (+4.2 pct)  
  Net                 14.24               17.79            14.00    
                   (-20.0 pct)         (-65.4 pct)      (-30.6 pct) 
  EPS              178.35 yen          222.93 yen       175.42 yen  
  EPS Diluted      178.12 yen          222.67 yen                   
  Ann Div                              110.00 yen       100.00 yen  
  -Q2 div           50.00 yen           50.00 yen                   
  -Q4 div                               60.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news